EDGE
Get a demo
Log In
All Updates

All Updates

icon
Filter
Product updates
RCE Technologies presents insights on biomarker study based on Infrasensor wearable device
Precision Medicine
May 8, 2024
This week:
Product updates
Stability AI launches Stable Diffusion 3 Medium, a text-to-image model
Foundation Models
Yesterday
Product updates
Microsoft discontinues GPT Builder in Copilot
Generative AI Applications
Yesterday
Funding
BlinqIO raises USD 5 million in funding to expand operations
Generative AI Applications
Yesterday
Product updates
Databricks launches innovations to Mosaic AI for production-quality applications
Generative AI Infrastructure
Yesterday
M&A
Rebellions and Sapeon Korea merge to challenge global AI chip leader
Generative AI Infrastructure
Yesterday
M&A
Pluxee to acquire Cobee; expands employee benefits offering
Remote Work Infrastructure
Yesterday
Product updates
Space and Time launches 'Proof of SQL' solution on GitHub
Enterprise Blockchain Solutions
Yesterday
Partnerships
Lido partners with Mellow Finance to launch liquid restaking vaults
Decentralized Finance (DeFi)
Yesterday
Funding
Rivia raises EUR 3 million in seed funding
Clinical Trial Technology
Yesterday
Partnerships
Product updates
Databricks and Shutterstock collaborate to launch enterprise-optimized ImageAI model
Generative AI Infrastructure
Yesterday
Precision Medicine

Precision Medicine

May 8, 2024

RCE Technologies presents insights on biomarker study based on Infrasensor wearable device

Product updates

  • RCE Technologies announced its groundbreaking advancements in its wearable-enabled biomarker studies at the 18th Annual Biomarker Symposium. The company presented its patented wearable device, Infrasensor, designed for gathering biochemical data.

  • The Infrasensor uses infrared technology in its operation. Being non-invasive, it aids in monitoring cardiac injury by providing real-time analysis paired with AI. The device was tested in a trial involving 840 individuals from 10 hospitals across the US. The device was used for three minutes while blood samples were gathered for biochemical analysis.

  • RCE Technologies specializes in developing non-invasive infrared-based wearable monitoring devices focusing on cardiovascular health. RCE Technologies' services are powered by its proprietary technology, including Infrasensor, which is a non-invasive transdermal device to measure cardiac conditions; infra-mind AI/ML platform that predicts heart attacks; and Infra-weave cloud service, which hosts, processes, and analyzes clinical and research data.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.